Predictors of time to relapse following ustekinumab withdrawal in patients with psoriasis who had responded to therapy: An 8-year multicenter study.
J Am Acad Dermatol
; 88(1): 71-78, 2023 01.
Article
en En
| MEDLINE
| ID: mdl-30703455
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Ustekinumab
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
J Am Acad Dermatol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Taiwán